Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 24, 2024Antimicrobial Agents and ChemotherapyOpen Access

Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating Plasmodium vivax malaria in the central highlands of Vietnam

View Full Paper
Ask AI
Bookmark
Share

Authors

NMNguyen Duc ManhNational University of Civil EngineeringNTNguyễn Văn ThànhCan Tho UniversityHQHuynh Hong QuangWellcome Sanger Institute

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Manh et al. (2024) studied this question.

synapsesocial.com/papers/68e5f3eeb6db6435875883a4https://doi.org/10.1128/aac.00044-24
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pyronaridine-Artesunate (Pyramax) for Treatment of Artemisinin- and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of Vietnam2021 · 18 citations
  2. 2Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria2013 · 308 citations
  3. 3Benefits of a Pharmacology Antimalarial Reference Standard and Proficiency Testing Program Provided by the Worldwide Antimalarial Resistance Network (WWARN)2014 · 28 citations
  4. 4Efficacy and safety of pyronaridine-artesunate (Pyramax®) for the treatment of uncomplicated Plasmodium vivax malaria in Northwest Ethiopia2022 · 6 citations
  5. 5Efficacy and Safety of Pyronaridine-Artesunate plus Single-Dose Primaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Eastern Cambodia2019 · 23 citations